Tag Archives: Alabama Defense Lawyer

CDC picks APhA Foundation to put diabetes prevention program in pharmacies – APhA submits compounding comments to FDA.

Alabama Defense Lawyer, Board of Pharmacy, Pharmacy Defense Attorney, KLF CDC picks APhA Foundation to put diabetes prevention program in pharmacies – APhA submits compounding comments to FDA. – (866) 348-2889 CDC has selected the APhA Foundation, in partnership with … Continue reading

Posted in Pharmacist | Tagged , , , | Leave a comment

Energy and Commerce Committee Investigates Imported or Domestic Pill Press Machines, Requests Details From DEA – APhA submits compounding comments to FDA.

Alabama Defense Lawyer, Board of Pharmacy, Pharmacy Defense Attorney, KLF Energy and Commerce Committee Investigates Imported or Domestic Pill Press Machines, Requests Details From DEA – APhA submits compounding comments to FDA. – (866) 348-2889 The House of Representatives Committee … Continue reading

Posted in Pharmacist | Tagged , , , | Comments Off

Hospitals can improve high-alert med safety procedures with self-assessment – APhA submits compounding comments to FDA.

Alabama Defense Lawyer, Board of Pharmacy, Pharmacy Defense Attorney, KLF Hospitals can improve high-alert med safety procedures with self-assessment – APhA submits compounding comments to FDA. – (866) 348-2889 Hospitals in the United States are required to identify and maintain … Continue reading

Posted in Pharmacist | Tagged , , , | Comments Off

PTCB Completes Beta Exam for the Sterile Compounding Certification Program – APhA submits compounding comments to FDA.

Alabama Defense Lawyer, Board of Pharmacy, Pharmacy Defense Attorney, KLF PTCB Completes Beta Exam for the Sterile Compounding Certification Program – APhA submits compounding comments to FDA. – (866) 348-2889 The Pharmacy Technician Certification Board (PTCB) has successfully completed the … Continue reading

Posted in Pharmacist | Tagged , , , | Comments Off

FDA approves first two-drug regimen for certain patients with HIV – APhA submits compounding comments to FDA.

Alabama Defense Lawyer, Board of Pharmacy, Pharmacy Defense Attorney, KLF FDA approves first two-drug regimen for certain patients with HIV – APhA submits compounding comments to FDA. – (866) 348-2889 FDA on Tuesday approved dolutegravir + rilpivirine (Juluca—ViiV Healthcare), the … Continue reading

Posted in Pharmacist | Tagged , , , | Comments Off

DEA Reports Strong Turnout for 14th Prescription Drug Take-Back Day – APhA submits compounding comments to FDA.

Alabama Defense Lawyer, Board of Pharmacy, Pharmacy Defense Attorney, KLF DEA Reports Strong Turnout for 14th Prescription Drug Take-Back Day – APhA submits compounding comments to FDA. – (866) 348-2889 More than 900,000 pounds of unneeded, unwanted, or expired prescription … Continue reading

Posted in Pharmacist | Tagged , , , | Comments Off

New Study Finds One in Five Drivers Use a Prescription Drug That Can Impair Driving Despite Warnings – APhA submits compounding comments to FDA.

Alabama Defense Lawyer, Board of Pharmacy, Pharmacy Defense Attorney, KLF New Study Finds One in Five Drivers Use a Prescription Drug That Can Impair Driving Despite Warnings – APhA submits compounding comments to FDA. – (866) 348-2889 A new study, … Continue reading

Posted in Pharmacist | Tagged , , , | Comments Off

Big changes could be in store for 2019 Medicare drug plans – APhA submits compounding comments to FDA.

Alabama Defense Lawyer, Board of Pharmacy, Pharmacy Defense Attorney, KLF Big changes could be in store for 2019 Medicare drug plans – APhA submits compounding comments to FDA. – (866) 348-2889 For the first time in 3 years, the CMS … Continue reading

Posted in Pharmacist | Tagged , , , | Comments Off

Comparative effectiveness of XR naltrexone vs. buprenorphine-naloxone for opioid relapse prevention – APhA submits compounding comments to FDA.

Alabama Defense Lawyer, Board of Pharmacy, Pharmacy Defense Attorney, KLF Comparative effectiveness of XR naltrexone vs. buprenorphine-naloxone for opioid relapse prevention – APhA submits compounding comments to FDA. – (866) 348-2889 New research indicates that extended release naltrexone (XR-NTX) and … Continue reading

Posted in Pharmacist | Tagged , , , | Comments Off

Reducing prescription drug costs, reducing administrative burden both key for CMS – APhA submits compounding comments to FDA.

Alabama Defense Lawyer, Board of Pharmacy, Pharmacy Defense Attorney, KLF Reducing prescription drug costs, reducing administrative burden both key for CMS – APhA submits compounding comments to FDA. – (866) 348-2889 CMS Administrator Seema Verma said this weekend the agency … Continue reading

Posted in Pharmacist | Tagged , , , | Comments Off